Posard Matthew L. has filed 14 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 3796 shares of HALOZYME THERAPEUTICS, INC. ($HALO) on May 05, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Director | A | Common Stock | 3796 | $0.00 | 77,835.0000 | 123,904,000 | 5.13% | 0.00% |
| May 5, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Director | A | Option to Purchase Common Stock | 6040 | $0.00 | 6,040.0000 | 123,904,000 | 9999.99% | 0.00% |
| June 23, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Posard Matthew L. | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 126,148,469 | 9999.99% | 0.04% |
| May 1, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | A | Common Stock | 4165 | $0.00 | 74,039.0000 | 129,424,000 | 5.96% | 0.00% |
| May 1, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | A | Option to Purchase Common Stock | 5750 | $0.00 | 5,750.0000 | 129,424,000 | 9999.99% | 0.00% |
| Aug. 12, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | S | Common Stock | 10000 | $55.72 | 89,755.0000 | 134,197,000 | 10.02% | 0.01% |
| Aug. 14, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | S | Common Stock | 9881 | $57.70 | 69,874.0000 | 134,197,000 | 12.39% | 0.01% |
| Aug. 13, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | S | Common Stock | 10000 | $56.19 | 79,755.0000 | 134,197,000 | 11.14% | 0.01% |
| June 14, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Posard Matthew L. | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | S | Common Stock | 10000 | $50.01 | 109,755.0000 | 134,197,000 | 8.35% | 0.01% |
| June 12, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | S | Common Stock | 10000 | $50.62 | 99,755.0000 | 134,197,000 | 9.11% | 0.01% |
| April 25, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | A | Option to Purchase Common Stock | 8804 | $0.00 | 8,804.0000 | 134,197,000 | 9999.99% | 0.01% |
| April 25, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | Posard Matthew L. | Not found | A | Common Stock | 6501 | $0.00 | 119,755.0000 | 134,197,000 | 5.74% | 0.00% |
| June 15, 2023 | Nautilus Biotechnology, Inc. | $NAUT | Posard Matthew L. | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |